206 related articles for article (PubMed ID: 24738973)
1. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.
Shinawi M; Coorg R; Shimony JS; Grange DK; Al-Kateb H
Clin Genet; 2015 May; 87(5):478-82. PubMed ID: 24738973
[TBL] [Abstract][Full Text] [Related]
2. Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia with or without intellectual disability.
Thevenon J; Lopez E; Keren B; Heron D; Mignot C; Altuzarra C; Béri-Dexheimer M; Bonnet C; Magnin E; Burglen L; Minot D; Vigneron J; Morle S; Anheim M; Charles P; Brice A; Gallagher L; Amiel J; Haffen E; Mach C; Depienne C; Doummar D; Bonnet M; Duplomb L; Carmignac V; Callier P; Marle N; Mosca-Boidron AL; Roze V; Aral B; Razavi F; Jonveaux P; Faivre L; Thauvin-Robinet C
J Med Genet; 2012 Jun; 49(6):400-8. PubMed ID: 22693284
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
[TBL] [Abstract][Full Text] [Related]
4. CAMTA1-related disorder: Phenotypic and molecular characterization of 26 new individuals and literature review.
Al-Kateb H; Au PYB; Berland S; Cogne B; Demurger F; Fluss J; Isidor B; Frank LM; Varvagiannis K; Koolen DA; McDonald M; Montgomery S; Moortgat S; Deprez M; Karadurmus D; Paulsen J; Reis A; Rieger M; Vasileiou G; Willing M; Shinawi M
Clin Genet; 2024 Mar; 105(3):294-301. PubMed ID: 38044714
[TBL] [Abstract][Full Text] [Related]
5. Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I; Serranová T; Prouteau C; Colin E; Ziegler A; Winkelmann J; Jech R; Zech M
Neurogenetics; 2021 May; 22(2):137-141. PubMed ID: 33677721
[TBL] [Abstract][Full Text] [Related]
6. Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants.
Jacobs EZ; Brown K; Byler MC; D'haenens E; Dheedene A; Henderson LB; Humberson JB; van Jaarsveld RH; Kanani F; Lebel RR; Millan F; Oegema R; Oostra A; Parker MJ; Rhodes L; Saenz M; Seaver LH; Si Y; Vanlander A; Vergult S; Callewaert B
Clin Genet; 2021 Feb; 99(2):259-268. PubMed ID: 33131045
[TBL] [Abstract][Full Text] [Related]
7. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability.
Wijnen IGM; Veenstra-Knol HE; Vansenne F; Gerkes EH; de Koning T; Vos YJ; Tijssen MAJ; Sival D; Darin N; Vanhoutte EK; Oosterloo M; Pennings M; van de Warrenburg BP; Kamsteeg EJ
Eur J Hum Genet; 2020 Jun; 28(6):763-769. PubMed ID: 32157189
[TBL] [Abstract][Full Text] [Related]
8. Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders.
Shi S; Lin S; Chen B; Zhou Y
Mol Med Rep; 2017 Nov; 16(5):6837-6845. PubMed ID: 28901431
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.
Katoh M; Katoh M
Int J Oncol; 2003 Oct; 23(4):1219-24. PubMed ID: 12964007
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND).
Vera G; Sorlin A; Delplancq G; Lecoquierre F; Brasseur-Daudruy M; Petit F; Smol T; Ziegler A; Bonneau D; Colin E; Mercier S; Cogné B; Bézieau S; Edery P; Lesca G; Chatron N; Sabatier I; Duban-Bedu B; Colson C; Piton A; Durand B; Capri Y; Perrin L; Wiesener A; Zweier C; Maroofian R; Carroll CJ; Galehdari H; Mazaheri N; Callewaert B; Giulianno F; Zaafrane-Khachnaoui K; Buchert-Lo R; Haack T; Magg J; Rieß A; Blandfort M; Waldmüller S; Horber V; Leonardi E; Polli R; Turolla L; Murgia A; Frebourg T; Lebre AS; Nicolas G; Saugier-Veber P; Guerrot AM
Eur J Med Genet; 2020 Oct; 63(10):104004. PubMed ID: 32688057
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
[TBL] [Abstract][Full Text] [Related]
15. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement.
Ha SY; Choi IH; Han J; Choi YL; Cho JH; Lee KJ; Sun JM
Lung Cancer; 2014 Mar; 83(3):411-5. PubMed ID: 24461304
[TBL] [Abstract][Full Text] [Related]
16. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
[TBL] [Abstract][Full Text] [Related]
17. Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
Henrich KO; Claas A; Praml C; Benner A; Mollenhauer J; Poustka A; Schwab M; Westermann F
Eur J Cancer; 2007 Feb; 43(3):607-16. PubMed ID: 17222547
[TBL] [Abstract][Full Text] [Related]
18. A novel maternally inherited 8q24.3 and a rare paternally inherited 14q23.3 CNVs in a family with neurodevelopmental disorders.
Hu J; Sathanoori M; Kochmar S; Azage M; Mann S; Madan-Khetarpal S; Goldstein A; Surti U
Am J Med Genet A; 2015 Aug; 167A(8):1921-6. PubMed ID: 25866352
[TBL] [Abstract][Full Text] [Related]
19. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.
Lesch KP; Selch S; Renner TJ; Jacob C; Nguyen TT; Hahn T; Romanos M; Walitza S; Shoichet S; Dempfle A; Heine M; Boreatti-Hümmer A; Romanos J; Gross-Lesch S; Zerlaut H; Wultsch T; Heinzel S; Fassnacht M; Fallgatter A; Allolio B; Schäfer H; Warnke A; Reif A; Ropers HH; Ullmann R
Mol Psychiatry; 2011 May; 16(5):491-503. PubMed ID: 20308990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
